Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY™ (Pemetrexed for Injection)
— Eagle has exclusive rights to commercialize product for four months beginning February 1, 2022 — WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle…
Pharmaceuticals, Biotechnology and Life Sciences
— Eagle has exclusive rights to commercialize product for four months beginning February 1, 2022 — WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle…
NEW YORK–(BUSINESS WIRE)–TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that Catalia Health…
Experienced executive to lead corneal disease clinical program for TTHX1114 SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics today announced the appointment of Thomas M.…
Arctoris Ltd has announced a formal partnership with Molecule in order to tackle the ongoing innovation crisis faced by drug…
– Forming Workforce Coalition in Frederick to address issues tied to attracting and retaining human capital – Coordinating with Universities…
SAN DIEGO–(BUSINESS WIRE)–PrecisionMed Inc., the world’s leading supplier of human cerebral spinal fluid (CSF), today announced enrollment of the first…
Transaction Provides Immediate Cash Infusion of $30M at Premium to Market Price of $2.50/share SAN DIEGO & PENNINGTON, N.J.–(BUSINESS WIRE)–OncoSec…
– Company also provides update on timeline for pivotal ZEPHYR study – ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo Therapeutics, Inc. (Nasdaq: MLND),…
NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to…
NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to…